Stocks and Investing
Stocks and Investing
Wed, November 24, 2021
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Tue, November 23, 2021
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Chi Fong Initiated (CCCC) at Strong Buy and Held Target at $54 on, Nov 23rd, 2021
Chi Fong of B of A Securities, Initiated "C4 Therapeutics, Inc." (CCCC) at Strong Buy and Held Target at $54 on, Nov 23rd, 2021.
Chi has made no other calls on CCCC in the last 4 months.
There are 2 other peers that have a rating on CCCC. Out of the 2 peers that are also analyzing CCCC, 1 agrees with Chi's Rating of Hold. Following is the relevant analyst calls for the last 4 months
- Bradley Canino of "Stifel" Initiated at Hold and Held Target at $45 on, Thursday, September 30th, 2021
This is the rating of the analyst that currently disagrees with Chi
- Andrew Berens of "SVB Leerink" Initiated at Buy and Held Target at $67 on, Thursday, October 14th, 2021
Contributing Sources